Phase 3 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your vaccinations are up to date based on the recommendations where you live (a specific shingles vaccine is encouraged but not required).
- You have been diagnosed with Discoid Lupus Erythematosus (a type of lupus that affects the skin, causing scarring rashes) and/or Subacute Cutaneous Lupus Erythematosus (another skin form of lupus), with or without also having Systemic Lupus Erythematosus (lupus that can affect the whole body).
- You have a certain active form of skin lupus called Acute Cutaneous Lupus Erythematosus as your only skin symptom, alongside Systemic Lupus Erythematosus, and it has been present for at least 6 weeks before your first study visit.
- If you have Systemic Lupus Erythematosus, your diagnosis meets specific internationally recognised medical classification standards (confirm with trial site).
- If you have Systemic Lupus Erythematosus, you have had your skin or lupus condition for at least 6 months since diagnosis.
- If you have Systemic Lupus Erythematosus, your skin lupus is currently active enough to reach a certain score on a standard medical measurement scale used by doctors (confirm with trial site).
- Additional eligibility requirements set by the trial may also apply.
Who may not be able to join:
- You have been primarily diagnosed with a different autoimmune or rheumatic disease (such as rheumatoid arthritis or systemic sclerosis) that is not lupus of the skin or Systemic Lupus Erythematosus.
- You have another skin condition unrelated to lupus (such as psoriasis), another serious uncontrolled illness (such as severe asthma or certain lung conditions), or a life-threatening form of lupus (such as active inflammation of the blood vessels), which the study doctors consider too risky for participation.
- Your lupus was caused by a medication you have taken (known as drug-induced lupus).
- You have active kidney inflammation caused by lupus and are currently receiving or have recently finished (within the last 3 months) an intensive treatment course for it (note: stable, ongoing lower-level kidney treatment may still be allowed — confirm with trial site).
- Your kidney test results show certain levels of protein in your urine or reduced kidney function that fall outside the limits set by the trial (confirm with trial site for specific values).
- You have had any active signs, symptoms, or a diagnosis of lupus affecting your brain or nervous system in the past 3 months, or you have a history of seizures that are not well controlled.
- Additional exclusion requirements set by the trial may also apply.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Responsible, Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phone: 888-275-7376
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants With Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) 70 Response, Defined as >= 70 Percent (%) Decrease in CLASI-A Score From Baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.